The Challenges in Using Immune Checkpoint Inhibitors to Treat Patients With Glioblastoma

July 14, 2016
David A. Reardon, MD

David A. Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses the important considerations and challenges in using immune checkpoint inhibitors to treat patients with glioblastoma.